CN105077233A - 大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 - Google Patents
大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 Download PDFInfo
- Publication number
- CN105077233A CN105077233A CN201510334172.7A CN201510334172A CN105077233A CN 105077233 A CN105077233 A CN 105077233A CN 201510334172 A CN201510334172 A CN 201510334172A CN 105077233 A CN105077233 A CN 105077233A
- Authority
- CN
- China
- Prior art keywords
- mulberries
- rich tea
- mixture
- dried
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 24
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 22
- 241000218231 Moraceae Species 0.000 title claims abstract description 21
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 11
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 239000011669 selenium Substances 0.000 title abstract description 21
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title abstract description 8
- 150000004676 glycans Chemical class 0.000 title abstract description 7
- 239000005996 Blood meal Substances 0.000 title abstract description 6
- 241001122767 Theaceae Species 0.000 title abstract 5
- 241001253208 Andrias davidianus Species 0.000 title abstract 4
- 239000008280 blood Substances 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 7
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 4
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 4
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 4
- 239000011781 sodium selenite Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims description 22
- 241000157862 Dicamptodontidae Species 0.000 claims description 17
- -1 polyphenol polysaccharide Chemical class 0.000 claims description 14
- 230000003712 anti-aging effect Effects 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 4
- 240000000249 Morus alba Species 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 229940091258 selenium supplement Drugs 0.000 abstract description 7
- 230000003405 preventing effect Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 108091005658 Basic proteases Proteins 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 14
- 150000003254 radicals Chemical class 0.000 description 7
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000005578 Rivina humilis Species 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种大鲵血液粉、富硒茶多酚多糖、桑葚混合物的制备方法及其作用。其特征在于:以质量百分比计,大鲵血液粉30%、富硒茶多酚多糖25-30%、桑葚45-40%。对大鲵血液过滤后,真空冷冻干燥,低温粉碎成200目血粉。在pH8.2,温度45℃,加入1%碱性蛋白酶,富硒茶粉与0.8%亚硒酸钠水溶液按1∶15提取2h,过滤,干燥成富硒茶多酚多糖蛋白。成熟桑葚清洗,臭氧水消毒,60℃干燥10h,真空冷冻干燥24h,粉碎成40目,除去种子及果梗,再粉碎成200目。按比例的混合物制成胶囊、片剂、粉剂和颗粒,长期日服用2G,具有抗氧化、抗衰老、预防肿瘤保健功能。
Description
技术领域
本发明属于保健食品技术领域,具体涉及含大鲵血粉、富硒茶多酚多糖、桑葚的混合物,具有抗氧化、抗衰老的保健作用。
背景技术
自由基与心血管疾病、肿瘤、肺气肿、白内障及人体衰老有密切关联,自由基作用于核酸引起碱基与核糖的断裂、核糖的氧化,导致核酸碱基破坏,产生遗传突变,导致细胞死亡;自由基使蛋白质分子发生交联,生成变性的高聚物,导致酶生物活性的丧失;自由基使多糖断裂,细胞膜寡糖链中糖分子羟基氧化,生成不饱和的羰基或聚合成双聚物,影响细胞免疫功能的发挥;自由基使多不饱和脂肪酸发生过氧化反应,导致膜通透性的变化,严重影响膜的各种生理功能;消除自由基是抗氧化、抗衰老、提高免疫力、预防肿瘤的根本性作用。
大鲵为两栖爬行动物,是脊椎动物进化史上由水生向陆生的过渡类型,具有较强的耐饥能力和抗衰老能力,人工养殖的子二代商品大鲵宰杀时间产生50-100ml血液,血液中含有多种血清蛋白、糖蛋白,Mn、Fe、Zn-SOD超岐氧化酶。桑葚中含有丰富的花青素、芦丁、杨梅酮、芸香苷、磷脂酰胆碱、白藜芦醇,微量元素钼、硒。在富硒绿茶在提取多酚茶多糖过程与硒结合,形成富硒茶多酚多糖有抗氧化、抗衰老、提高免疫力和预防肿瘤的作用。
发明内容
本发明的目的利用大鲵血液,桑葚和富硒茶多酚多糖混合物协同清除自由基,抗氧化、抗衰老、预防肿瘤保健功能。
实现上述目的的技术方案是:大鲵血液粉,富硒茶多酚多糖、桑葚的混合物,其特征在于:按质量百分比,大鲵血液粉30%、富硒茶多酚多糖25-30%、桑葚45-40%。
大鲵血液过滤后,真空冷冻干燥,低温粉碎成200目血粉。在温度45℃,pH8.2,加入1%碱性蛋白酶,富硒茶粉与0.8%亚硒酸钠水溶液按1∶15提取2h,过滤,干燥成富硒茶多酚多糖蛋白。成熟桑葚清洗,臭氧水消毒,60℃干燥10h,真空冷冻干燥24h,粉碎成40目,除去种子和果梗,再粉碎成200目。
具体实施方式,下面结合实施例对本发明作进一步说明。
(1)大鲵血液粉,富硒茶多酚多糖、桑葚的混合物,其特征在于:按质量百分比,大鲵血液粉30%、富硒茶多酚多糖25-30%、桑葚45-40%。
(2)鲵血液过滤后,真空冷冻干燥,低温粉碎成200目血粉。
(3)成熟桑葚清洗,臭氧水消毒,60℃干燥10h,真空冷冻干燥24h,粉碎成40目,除去种子和果梗,再粉碎成200目。
(4)以质量分数计,在温度45℃,pH8.2,加入1%碱性蛋白酶,富硒茶粉与0.8%亚硒酸钠水溶液按1∶15提取2h,过滤,干燥成富硒茶多酚多糖蛋白。
(5)大鲵血液粉,富硒茶多酚多糖、桑葚的混合物制成胶囊、压片或粉剂,日服量2G,具有抗氧化、抗衰老、预防肿瘤保健功能。
Claims (3)
1.大鲵血液粉、富硒茶多酚多糖、桑葚的混合物制备方法及其其作用。其特征在于:按质量百分比,大鲵血液粉30%、富硒茶多酚多糖25-30%、桑葚45-40%。
2.按照权利要求1所述的大鲵血液粉、富硒茶多酚多糖、桑葚的混合物,其特征在于:以质量分数计,对大鲵血液过滤后,真空冷冻干燥,低温粉碎成200目血粉。在温度45℃,pH8.2,加入1%碱性蛋白酶,富硒茶粉与0.8%亚硒酸钠水溶液按1∶15提取2h,过滤,干燥成富硒茶多酚多糖蛋白。成熟桑葚清洗,臭氧水消毒,60℃干燥10h,真空冷冻干燥24h,粉碎成40目,除去种子和果梗,再粉碎成200目。
3.按照权利要求1所述的大鲵血液粉,富硒茶多酚多糖、桑葚的混合物,其特征在于:大鲵血液粉,富硒茶多酚多糖、桑葚的混合物制成胶囊、压片或粉剂,日服量2G,具有抗氧化、抗衰老、预防肿瘤保健功能。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510334172.7A CN105077233A (zh) | 2015-06-09 | 2015-06-09 | 大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510334172.7A CN105077233A (zh) | 2015-06-09 | 2015-06-09 | 大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105077233A true CN105077233A (zh) | 2015-11-25 |
Family
ID=54559282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510334172.7A Pending CN105077233A (zh) | 2015-06-09 | 2015-06-09 | 大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105077233A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106107397A (zh) * | 2016-06-27 | 2016-11-16 | 张博 | 一种大鲵蛋白肽粉固体饮料配方及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101366425A (zh) * | 2008-09-16 | 2009-02-18 | 无锡太阳绿宝科技有限公司 | 一种富硒速溶绿茶粉的制备工艺 |
CN103300375A (zh) * | 2013-06-27 | 2013-09-18 | 叶建斌 | 一种益气养血的脆片及制备方法 |
CN103349193A (zh) * | 2013-06-01 | 2013-10-16 | 张家界金鲵生物工程股份有限公司 | 一种大鲵营养粉及其生产方法 |
-
2015
- 2015-06-09 CN CN201510334172.7A patent/CN105077233A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101366425A (zh) * | 2008-09-16 | 2009-02-18 | 无锡太阳绿宝科技有限公司 | 一种富硒速溶绿茶粉的制备工艺 |
CN103349193A (zh) * | 2013-06-01 | 2013-10-16 | 张家界金鲵生物工程股份有限公司 | 一种大鲵营养粉及其生产方法 |
CN103300375A (zh) * | 2013-06-27 | 2013-09-18 | 叶建斌 | 一种益气养血的脆片及制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106107397A (zh) * | 2016-06-27 | 2016-11-16 | 张博 | 一种大鲵蛋白肽粉固体饮料配方及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
García-Vaquero et al. | Polysaccharides from macroalgae: Recent advances, innovative technologies and challenges in extraction and purification | |
CN103755822B (zh) | 一种莼菜多糖的制备方法 | |
CN103194516A (zh) | 蛹虫草多肽的制备方法 | |
CN105602761A (zh) | 一种含有植物性粘多糖的润肤性手工皂及其热制制备方法 | |
CN108047343B (zh) | 伊贝母总多糖的制备方法及其应用 | |
CN104382953A (zh) | 一种黑木耳黑色素的提取方法 | |
CN103262998B (zh) | 野生黑枸杞片剂及制作方法 | |
CN103382255B (zh) | 一种高抗氧化特性的玉米蛋白膜的制备方法 | |
CN104938604A (zh) | 一种水产加工下脚料综合利用方法 | |
CN103689212A (zh) | 一种动物鲜骨提取小分子肽的方法 | |
CN104611310A (zh) | 从辣木叶中提取蛋白质和超氧化物歧化酶(sod)的工艺 | |
CN104262430A (zh) | 一种从枳实超声提取橙皮苷的方法 | |
KR101416545B1 (ko) | 폐식용유를 이용한 주방용 액상 세제의 제조방법 | |
CN105077233A (zh) | 大鲵血粉、富硒茶多糖多酚、桑葚的混合物制备及其作用 | |
CN103805666B (zh) | 一种利用胰酶水解米渣制备抗氧化活性肽的方法 | |
CN103864944A (zh) | 一种滑菇多糖粗品的制备方法 | |
CN107177579B (zh) | 一种利用蒜片加工废水制备蒜氨酸酶、大蒜辣素和大蒜多糖的方法 | |
CN105367680A (zh) | 一种微波辅助提取黑木耳多糖的方法 | |
CN103829242A (zh) | 一种含有白刺果红色素的保健食品 | |
CN101433322B (zh) | 一种富含花青素的功能食品及其制备方法 | |
CN104693312B (zh) | 紫珠草中多种有效成分同时提取的方法及应用 | |
CN103305359A (zh) | 一种香菇啤酒及生产方法 | |
CN110547355A (zh) | 一种利用水酶法大豆水解液制备功能性蛋白复合物的方法 | |
CN104419610A (zh) | 一种保健酒及其生产方法 | |
CN103211165A (zh) | 一种金银花面条及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151125 |
|
WD01 | Invention patent application deemed withdrawn after publication |